AZ-GHS-22

N/A

Report date: 2022/01/05 09:19:45

Base Information

Drug NameAZ-GHS-22

Drug Alias NameAZ-GHS-22

ClassificationOther

Mechanisms of ActionGhrelin/growth hormone secretagogue receptor antagonists

TargetsGhrelin/growth hormone secretagogue receptor

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsObesity

ATC CodeN/A